A Review of Traditional Chinese Medicine for Triple Negative Breast Cancer and the Pharmacological Mechanisms
Q Wu, H Yan, Z Kang - The American Journal of Chinese Medicine, 2024 - World Scientific
Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer.
Conventional treatment options for TNBC often have limited efficacy and significant side …
Conventional treatment options for TNBC often have limited efficacy and significant side …
A study of the role of androgen receptor and androgen receptor variant 7 in TNBC patients and the effect of their targeting by Enzalutamide and EPI-001 in MDA-MB …
BM Ali, HS El-Abhar, G Mohamed, HR Nassar… - The Journal of Steroid …, 2025 - Elsevier
The lack of targeted therapy for triple-negative breast cancer (TNBC) is among the
mainsprings of its poor prognosis. This study aimed to elucidate the role of the androgen …
mainsprings of its poor prognosis. This study aimed to elucidate the role of the androgen …
Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents
Aim With the aim of simultaneously modulating the epigenetic system and the protein kinase
pathway, we selected the enzyme histone deacetylase (HDAC) and the Rho-associated …
pathway, we selected the enzyme histone deacetylase (HDAC) and the Rho-associated …
Triptolide's Impact on ACER1 Signaling: Inducing Autophagy for Triple-Negative Breast Cancer Suppression
L Huang, R Xue, M Zhu, S Xu, Y Luo, C Qin… - … -Research and Practice, 2025 - Elsevier
Given the absence of estrogen receptor (ER), progesterone receptor (PR), and human
epidermal growth factor receptor-2 (Her-2) in triple-negative breast cancer (TNBC) cells, the …
epidermal growth factor receptor-2 (Her-2) in triple-negative breast cancer (TNBC) cells, the …